Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Esoteric
IP Royalties
Parent Companies
DRI Capital Inc
Drug Royalty LP
2018-1
Drug Royalty LP (DRUG) 2018-1
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
ABS
ESOT
PRCD
DRUG 2018-1 (USD 100m)
DRI Capital Inc
GSC
USOA
Nov 30, 2018
Class
CCY
SIZE (M)
WAL
MO
SP
FI
DR
KR
C/E
LTV
TYPE
BNCH
IPT
GDNC
SPRD
CPN
YLD
PRICE
W2
NLB
41.000
7.78
-
OOO
-
-
VVV
-
-
-
-
-
-
-
4.27%
4.300%
73.94501
F1
XHS
79.000
3.69
-
EEE
-
-
AAA
-
-
Afodapfv
3eW
-
-
160
3yO+160
-
959.00000
Filings
ABS-15G
Tranche Comments
F1: Registration: 144V Rixw; W2: Registration: 144I Pufo;
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
B&I
BWICS & Inventory
This module is available on the Professional plan.
Learn more
Upgrade Plan
TRACE
This module is available on the Professional plan.
Learn more
Upgrade Plan
Research
Log In
Missing something? Tell us.